Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biocitech, the Paris life science technology park that offers services for the development of biotechnology, biopharmaceutical and fine chemical companies, has appointed Jean-Francois Boussard as CEO with effect from April 1.
Subscribe to our email newsletter
Mr Boussard replaces Jacques Lhomel, who is taking retirement to pursue a number of personal projects.
Biocitech said that Mr Boussard, joins Biocitech after a long and successful biotechnology career in both academic and industry fields. From 1994, after six years as patents, licensing and legal director in a financial holding company, he was an independent consultant in enterprise creation and technology transfer.
Reportedly, in 1998, he founded and was CEO of Substrat, a consulting company specialised in enterprise creation and management, project management and technology transfer in the field of biotechnology.
Prior to Substrat, he was a manager for pharmaceuticals and biotechnology at France’s innovation agency, Anvar, from 1982 to 1988. From 1979-82, he was a biologist at LERS Synthelabo after an earlier spell as a research scientist at the University of Metz.
Mr Boussard, said: “I am delighted to join such a go-ahead organisation as Biocitech, one of the key players in biotechnology in France and Europe. I am looking forward to putting my scientific, legal and financial know-how to use to continue the rapid development of the park. My past experience means I know exactly how biotech companies work – and this should enable me to make a real contribution to the efforts made by the team at Biocitech to respond to the needs of our present and future resident companies.”